Navigation Links
Clinical Trials Offices Changing Academic Health Center Research Infrastructure
Date:8/27/2009

Strategic Examination and Consolidation of Services Recommended by the AAHC

WASHINGTON, Aug. 27 /PRNewswire-USNewswire/ -- Little uniformity exists in the structure or functions of clinical trials offices, and models are needed for the future, according to Clinical Trials Offices: What's New in Research Administration?, a new report from the Association of Academic Health Centers (AAHC). Emerging centralized clinical trial offices (CTOs) are among the newest developments within the research administration infrastructure of academic health centers -- where leaders are focused on optimizing resources and developing strategies to sustain and transform the nation's research enterprise. The report notes that a trend towards consolidation or centralization in the administration of clinical trial functions has been ongoing for several years -- but is far from accomplished.

Report authors, Elaine Rubin, AAHC vice president for policy and program, and Danielle Lazar, AAHC program associate, profiled eight academic health centers, addressing the development, organization, structure, and activities of the clinical trials office (CTO). Operating budgets of profiled CTOs ranged from $400 thousand to over $4 million with compliance responsibilities that ranged from contracting and cost analysis to education and training.

The report not only provides important insights on the strategies and initiatives to create systems for the future but also institutional cultural change and the challenges that academic health center leaders face to ensure the research enterprise evolves to address new scientific developments, translational research, and interdisciplinary, multisite research.

Study findings reveal that many institutions are still stressed and challenged by the lack of a clearly defined organization and governance structure for clinical trials administration. "Academic health center leaders should examine the organization and structure for clinical trials administration within their respective institutions and determine what, if any, changes are needed to consolidate and optimize the research infrastructure," said Dr. Rubin, who also pointed out that important tools, such as the AAHC's Clinical Trials Administration Toolkit, exist to help with this process.

The AAHC is a national non-profit association dedicated to advancing the nation's health and well-being through the vigorous leadership of academic health centers.


'/>"/>
SOURCE Association of Academic Health Centers
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
3. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
4. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
5. PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials
6. Clinical Data Acquires Epidauros Biotechnologie AG, Significantly Enhancing Proprietary Genetic Biomarker Portfolio
7. ExonHit Therapeutics: Allergan and ExonHits First Collaboration Compound to Begin Human Clinical Trials
8. Sunesis Pharmaceuticals Announces Reorganization to Focus Resources and Build Value in Clinical-Stage Programs
9. Lorus Advances Clinical Development of GTI-2040 Combined with Ara-C in Acute Myeloid Leukemia
10. YM BioSciences USA cleared by US FDA to initiate Phase II clinical trial of nimotuzumab in children with inoperable, recurrent brain cancer
11. New Study Findings Confirm CLEXANE(R)/LOVENOX(R) Long-Term Clinical Benefit in Patients Suffering From Acute Coronary Syndrome
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... March 28, 2017 , ... T3D Therapeutics, Inc., a ... administered treatment for Alzheimer’s disease (AD), today announced that Dr. Kathleen Welsh-Bohmer has ... to uniquely treat the metabolic dysfunctions inherent in Alzheimer’s disease and advance the ...
(Date:3/28/2017)... ... 2017 , ... Executive search firm, Slone Partners, announces the ... is a distinguished life sciences expert with a proven track record in strategic ... wide range of services related to laboratory testing and analysis for the pharmaceutical, ...
(Date:3/27/2017)... WARREN, N.J. , March 27, 2017 Roka ... providing advanced testing solutions for the detection of foodborne pathogens, ... at the Sidoti & Company Spring 2017 Convention on March ... the New York Marriott Marquis. About Roka ... ...
(Date:3/27/2017)... ... 2017 , ... IsoPlexis Corporation (IsoPlexis), a venture capital-funded life ... through a single-cell precision engineering platform, today announced it has received an exclusive ... laboratory of Dr. James Heath at the California Institute of Technology, a pioneer ...
Breaking Biology Technology:
(Date:3/27/2017)... 2017  Catholic Health Services (CHS) has been ... (HIMSS) Analytics for achieving Stage 6 on the ... In addition, CHS previously earned a place in ... electronic medical record (EMR). "HIMSS Analytics ... EMR usage in an outpatient setting.  This recognition ...
(Date:3/24/2017)... 24, 2017 The Controller General of Immigration from ... Abdulla Algeen have received the prestigious international IAIR Award for the ... Continue Reading ... ... Controller Abdulla Algeen (small picture on the right) have received the IAIR ...
(Date:3/24/2017)... Research and Markets has announced the addition of the ... Forecast to 2025" report to their offering. ... The Global Biometric Vehicle Access System ... over the next decade to reach approximately $1,580 million by 2025. ... forecasts for all the given segments on global as well as ...
Breaking Biology News(10 mins):